Literature DB >> 31638097

Characteristic response of striatal astrocytes to dopamine depletion.

Yao-Feng Zhu1, Wei-Ping Wang2, Xue-Feng Zheng3, Zhi Chen3, Tao Chen3, Zi-Yun Huang3, Lin-Ju Jia3, Wan-Long Lei3.   

Abstract

Astrocytes and astrocyte-related proteins play important roles in maintaining normal brain function, and also regulate pathological processes in brain diseases and injury. However, the role of astrocytes in the dopamine-depleted striatum remains unclear. A rat model of Parkinson's disease was therefore established by injecting 10 μL 6-hydroxydopamine (2.5 μg/μL) into the right medial forebrain bundle. Immunohistochemical staining was used to detect the immunoreactivity of glial fibrillary acidic protein (GFAP), calcium-binding protein B (S100B), and signal transducer and activator of transcription 3 (STAT3) in the striatum, and to investigate the co-expression of GFAP with S100B and STAT3. Western blot assay was used to measure the protein expression of GFAP, S100B, and STAT3 in the striatum. Results demonstrated that striatal GFAP-immunoreactive cells had an astrocytic appearance under normal conditions, but that dopamine depletion induced a reactive phenotype with obvious morphological changes. The normal striatum also contained S100B and STAT3 expression. S100B-immunoreactive cells were uniform in the striatum, with round bodies and sparse, thin processes. STAT3-immunoreactive cells presented round cell bodies with sparse processes, or were darkly stained with a large cell body. Dopamine deprivation induced by 6-hydroxydopamine significantly enhanced the immunohistochemical positive reaction of S100B and STAT3. Normal striatal astrocytes expressed both S100B and STAT3. Striatal dopamine deprivation increased the number of GFAP/S100B and GFAP/STAT3 double-labeled cells, and increased the protein levels of GFAP, S100B, and STAT3. The present results suggest that morphological changes in astrocytes and changes in expression levels of astrocyte-related proteins are involved in the pathological process of striatal dopamine depletion. The study was approved by Animal Care and Use Committee of Sun Yat-sen University, China (Zhongshan Medical Ethics 2014 No. 23) on September 22, 2014.

Entities:  

Keywords:  6-hydroxydopamine; Parkinson’s disease; S100B; STAT3; astrocyte; dopamine depletion; dopaminergic neurons; striatum

Year:  2020        PMID: 31638097     DOI: 10.4103/1673-5374.266917

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


  5 in total

Review 1.  Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions.

Authors:  Rishabh Khera; Sidharth Mehan; Sumit Kumar; Pranshul Sethi; Sonalika Bhalla; Aradhana Prajapati
Journal:  Mol Neurobiol       Date:  2022-04-18       Impact factor: 5.590

2.  Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model.

Authors:  Ana Flávia Fernandes Ferreira; Monique Patricio Singulani; Henning Ulrich; Zhong-Ping Feng; Hong-Shuo Sun; Luiz Roberto Britto
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

3.  Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease.

Authors:  Ludovica Iovino; Veronica Giusti; Francesca Pischedda; Elena Giusto; Nicoletta Plotegher; Antonella Marte; Ilaria Battisti; Angela Di Iacovo; Algerta Marku; Giovanni Piccoli; Rina Bandopadhyay; Carla Perego; Tiziana Bonifacino; Giambattista Bonanno; Cristina Roseti; Elena Bossi; Giorgio Arrigoni; Luigi Bubacco; Elisa Greggio; Sabine Hilfiker; Laura Civiero
Journal:  Acta Neuropathol       Date:  2022-05-21       Impact factor: 15.887

4.  Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson's Disease Model.

Authors:  Seulah Lee; Yeon Ji Suh; Seonguk Yang; Dong Geun Hong; Akihito Ishigami; Hangun Kim; Jae-Seoun Hur; Seung-Cheol Chang; Jaewon Lee
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

Review 5.  Neuron-Astrocyte Interactions in Parkinson's Disease.

Authors:  Ikuko Miyazaki; Masato Asanuma
Journal:  Cells       Date:  2020-12-07       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.